Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 2
1996 10
1999 23
2000 107
2001 88
2002 98
2003 113
2004 118
2005 185
2006 259
2007 423
2008 658
2009 803
2010 860
2011 791
2012 728
2013 816
2014 1109
2015 889
2016 981
2017 1164
2018 1209
2019 1159
2020 562
Text availability
Article attribute
Article type
Publication date

Search Results

10,588 results
Results by year
Filters applied: . Clear all
Page 1
Retraction notice to "Design, synthesis, and biological evaluation of heterotetracyclic quinolinone derivatives as anticancer agents targeting topoisomerases" [Eur. J. Med. Chem. 190 (2020) 112074].
Lee JF, Chang TY, Liu ZF, Lee NZ, Yeh YH, Chen YS, Chen TC, Chou HS, Li TK, Lee SB, Lin MH. Lee JF, et al. Eur J Med Chem. 2020 Aug 1;199:112490. doi: 10.1016/j.ejmech.2020.112490. Eur J Med Chem. 2020. PMID: 32546328
Corrigendum to "Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer" [Eur. J. Med. Chem. 163 (2019) 787-803].
Wang C, Wang B, Hou S, Xue L, Kang Z, Du J, Li Y, Liu X, Wang Q, Zhang C. Wang C, et al. Eur J Med Chem. 2020 Jan 15;186:111907. doi: 10.1016/j.ejmech.2019.111907. Epub 2019 Nov 30. Eur J Med Chem. 2020. PMID: 31791642 No abstract available.
Corrigendum to "Design and synthesis of novel artemisinin hybrids with potent activities against human colorectal cancer cells in vitro and in vivo" [Eur. J. Med. Chem. 182 (2019) 111665].
Wang LL, Kong L, Liu H, Zhang Y, Zhang L, Liu X, Yuan F, Li Y, Zuo Z. Wang LL, et al. Eur J Med Chem. 2020 May 15;194:112256. doi: 10.1016/j.ejmech.2020.112256. Epub 2020 Mar 25. Eur J Med Chem. 2020. PMID: 32220686 No abstract available.
Corrigendum to "Design, synthesis, and evaluation of N-phenyl-4-(2-phenylsulfonamido)-benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response" [Eur J Med Chem. 192 2020 112158].
Wu WC, Liu YM, Lin MH, Liao YH, Lai MJ, Chuang HY, Hung TY, Chen CH, Liou JP. Wu WC, et al. Eur J Med Chem. 2020 Jun 15;196:112329. doi: 10.1016/j.ejmech.2020.112329. Epub 2020 Apr 20. Eur J Med Chem. 2020. PMID: 32311605 No abstract available.
Corrigendum to "Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening" [Eur. J. Med. Chem. 179 (2019) 634-648].
Sari S, Kart D, Öztürk N, Kaynak FB, Gencel M, Taşkor G, Karakurt A, Saraç S, Eşsiz Ş, Dalkara S. Sari S, et al. Eur J Med Chem. 2020 Mar 15;190:112130. doi: 10.1016/j.ejmech.2020.112130. Eur J Med Chem. 2020. PMID: 32074493 No abstract available.
Development of selective mono or dual PROTAC degrader probe of CDK isoforms.
Zhou F, Chen L, Cao C, Yu J, Luo X, Zhou P, Zhao L, Du W, Cheng J, Xie Y, Chen Y. Zhou F, et al. Eur J Med Chem. 2020 Feb 1;187:111952. doi: 10.1016/j.ejmech.2019.111952. Epub 2019 Dec 6. Eur J Med Chem. 2020. PMID: 31846828
10,588 results
Jump to page
Feedback